170 related articles for article (PubMed ID: 19648108)
1. Targeting glucose consumption and autophagy in myeloma with the novel nucleoside analogue 8-aminoadenosine.
Shanmugam M; McBrayer SK; Qian J; Raikoff K; Avram MJ; Singhal S; Gandhi V; Schumacker PT; Krett NL; Rosen ST
J Biol Chem; 2009 Sep; 284(39):26816-30. PubMed ID: 19648108
[TBL] [Abstract][Full Text] [Related]
2. 8-Amino-adenosine induces loss of phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2, and Akt kinase: role in induction of apoptosis in multiple myeloma.
Ghias K; Ma C; Gandhi V; Platanias LC; Krett NL; Rosen ST
Mol Cancer Ther; 2005 Apr; 4(4):569-77. PubMed ID: 15827330
[TBL] [Abstract][Full Text] [Related]
3. KLF4-SQSTM1/p62-associated prosurvival autophagy contributes to carfilzomib resistance in multiple myeloma models.
Riz I; Hawley TS; Hawley RG
Oncotarget; 2015 Jun; 6(17):14814-31. PubMed ID: 26109433
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of autophagy with chloroquine potentiates carfilzomib-induced apoptosis in myeloma cells in vitro and in vivo.
Jarauta V; Jaime P; Gonzalo O; de Miguel D; Ramírez-Labrada A; Martínez-Lostao L; Anel A; Pardo J; Marzo I; Naval J
Cancer Lett; 2016 Nov; 382(1):1-10. PubMed ID: 27565383
[TBL] [Abstract][Full Text] [Related]
5. Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin.
Dalva-Aydemir S; Bajpai R; Martinez M; Adekola KU; Kandela I; Wei C; Singhal S; Koblinski JE; Raje NS; Rosen ST; Shanmugam M
Clin Cancer Res; 2015 Mar; 21(5):1161-71. PubMed ID: 25542900
[TBL] [Abstract][Full Text] [Related]
6. 8-Aminoadenosine enhances radiation-induced cell death in human lung carcinoma A549 cells.
Meike S; Yamamori T; Yasui H; Eitaki M; Matsuda A; Inanami O
J Radiat Res; 2011; 52(4):456-63. PubMed ID: 21785234
[TBL] [Abstract][Full Text] [Related]
7. Development of GLUT4-selective antagonists for multiple myeloma therapy.
Wei C; Bajpai R; Sharma H; Heitmeier M; Jain AD; Matulis SM; Nooka AK; Mishra RK; Hruz PW; Schiltz GE; Shanmugam M
Eur J Med Chem; 2017 Oct; 139():573-586. PubMed ID: 28837922
[TBL] [Abstract][Full Text] [Related]
8. Targeting autophagy in multiple myeloma.
Yun Z; Zhichao J; Hao Y; Ou J; Ran Y; Wen D; Qun S
Leuk Res; 2017 Aug; 59():97-104. PubMed ID: 28599191
[TBL] [Abstract][Full Text] [Related]
9. Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy.
McBrayer SK; Cheng JC; Singhal S; Krett NL; Rosen ST; Shanmugam M
Blood; 2012 May; 119(20):4686-97. PubMed ID: 22452979
[TBL] [Abstract][Full Text] [Related]
10. Autophagy and Myeloma.
Zheng Z; Wang L; Cheng S; Wang Y; Zhao W
Adv Exp Med Biol; 2020; 1207():625-631. PubMed ID: 32671780
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible hexokinase-2 enhances anti-apoptotic function via activating autophagy in multiple myeloma.
Ikeda S; Abe F; Matsuda Y; Kitadate A; Takahashi N; Tagawa H
Cancer Sci; 2020 Nov; 111(11):4088-4101. PubMed ID: 32790954
[TBL] [Abstract][Full Text] [Related]
12. A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells.
Milan E; Perini T; Resnati M; Orfanelli U; Oliva L; Raimondi A; Cascio P; Bachi A; Marcatti M; Ciceri F; Cenci S
Autophagy; 2015; 11(7):1161-78. PubMed ID: 26043024
[TBL] [Abstract][Full Text] [Related]
13. Autophagy inhibition enhances isobavachalcone-induced cell death in multiple myeloma cells.
Zhao S; Ma CM; Liu CX; Wei W; Sun Y; Yan H; Wu YL
Int J Mol Med; 2012 Oct; 30(4):939-44. PubMed ID: 22824846
[TBL] [Abstract][Full Text] [Related]
14. Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells.
Yao Z; Xie F; Li M; Liang Z; Xu W; Yang J; Liu C; Li H; Zhou H; Qu LH
Cell Death Dis; 2017 Feb; 8(2):e2633. PubMed ID: 28230866
[TBL] [Abstract][Full Text] [Related]
15. MARCKS inhibition cooperates with autophagy antagonists to potentiate the effect of standard therapy against drug-resistant multiple myeloma.
Zhang L; Rastgoo N; Wu J; Zhang M; Pourabdollah M; Zacksenhaus E; Chen Y; Chang H
Cancer Lett; 2020 Jun; 480():29-38. PubMed ID: 32220540
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of DEPTOR induces apoptosis, increases chemosensitivity to doxorubicin and suppresses autophagy in RPMI-8226 human multiple myeloma cells in vitro.
Zhang H; Chen J; Zeng Z; Que W; Zhou L
Int J Mol Med; 2013 May; 31(5):1127-34. PubMed ID: 23503641
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms for autophagy modulation by isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells.
Dykstra KM; Allen C; Born EJ; Tong H; Holstein SA
Oncotarget; 2015 Dec; 6(39):41535-49. PubMed ID: 26595805
[TBL] [Abstract][Full Text] [Related]
18. Iron chelators induce autophagic cell death in multiple myeloma cells.
Pullarkat V; Meng Z; Donohue C; Yamamoto VN; Tomassetti S; Bhatia R; Krishnan A; Forman SJ; Synold TW
Leuk Res; 2014 Aug; 38(8):988-96. PubMed ID: 24998390
[TBL] [Abstract][Full Text] [Related]
19.
Wu H; Liu C; Yang Q; Xin C; Du J; Sun F; Zhou L
Autophagy; 2020 Apr; 16(4):683-697. PubMed ID: 31242129
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10-Dependent Apoptosis by Carfilzomib and Selinexor.
Rosebeck S; Alonge MM; Kandarpa M; Mayampurath A; Volchenboum SL; Jasielec J; Dytfeld D; Maxwell SP; Kraftson SJ; McCauley D; Shacham S; Kauffman M; Jakubowiak AJ
Mol Cancer Ther; 2016 Jan; 15(1):60-71. PubMed ID: 26637366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]